Company

Disruptive precision medicine technology conquering inflammation and diabetes

Leadership Team

Josep Bassaganya- Riera

Executive Chairman, President & CEO

• 17 years of business development and fundraising experience in leading biotech companies.
• Developed innovative large-scale translational programs with focus on immune modulators, anti-inflammatories and anti-diabetic therapeutics.
• Identified and validated the role of novel therapeutic targets in diabetes and inflammatory bowel disease yielding over 15 patents.
• Experience in bioinformatics, computational modeling, pre-clinical efficacy and safety studies (rats mouse and pig models) as well as human clinical trials.
• Please email me at jbassaganya@biotherapeuticsinc.com